LorenSMichelMDMD

Head & Neck Cancer

Associate Member, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center

Overview of Dr. Michel

Dr. Loren Michel is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Overlook Medical Center. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 29 years. Dr. Michel accepts several types of health insurance, listed below. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 44 doctors at Overlook Medical Center who specialize in Oncology. He also speaks multiple languages, including Spanish. He has more than 50 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center Basking Ridge
136 Mountain View Boulevard
New York, NY 10021
Book by Phone+1(708) 546-4394
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 2000
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1994 - 1996
Cleveland Clinic FoundationInternship, Internal Medicine, 1988 - 1989
Case Western Reserve University School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License 2016 - 2025
CO State Medical License 2022 - 2025
NY State Medical License 1994 - 2025
PA State Medical License 2023 - 2024
MO State Medical License 2005 - 2017
OH State Medical License 1989 - 1996
TN State Medical License 1988 - 1992
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Start of enrollment: 2005 Sep 14
Recruiting
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
Completed
Phase 1
Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
Terminated
Phase 3
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2013 May 31
Completed
Phase 1
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03
Terminated
Phase 1, Phase 2
PD 0332991 and Cetuximab in Patients With Incurable SCCHN Start of enrollment: 2014 Jun 17
Completed
Phase 1, Phase 2
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer Start of enrollment: 2018 Sep 07
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Lee, N., Sherman, E., Schöder, H., Wray, R., Boyle, J., Singh, B., Grkovski, M., Paudyal, R., Cunningham, L., Zhang, Z., Hatzoglou, V., Katabi, N., Diplas, B., Han, J....> ;Journal of Clinical Oncology. 2024 Mar 10
Rebuttal to comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer".
James E Han, Kaveh Zakeri, Loren Michel, Eric J Sherman, Nancy Y Lee> ;Head & Neck. 2024 Jan 1
7 citations
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors.
Kuan, E., Wang, E., Adappa, N., Beswick, D., London, N., Su, S., Wang, M., Abuzeid, W., Alexiev, B., Alt, J., Antognoni, P., Alonso-Basanta, M., Batra, P., Bhayani, M....> ;International Forum of Allergy & Rhinology. 2024 Feb 1
7 citations
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Joris L Vos, Bharat Burman, Swati Jain, Conall W R Fitzgerald, Eric J Sherman, Lara A Dunn, James V Fetten, Loren S Michel, Anuja Kriplani, Kenneth K Ng, Juliana Eng, ...> ;Nature Medicine. 2023 Dec 1
1 citations
Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
James Han, Kaveh Zakeri, Gabriel Raab, Jennifer Hesse, Achraf Shamseddine, Linda Chen, Yao Yu, Jung Julie Kang, Sean M McBride, Nadeem Riaz, C Jillian Tsai, Daphna Gel...> ;Head & Neck. 2023 Sep 1
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Yao Yu, Heiko Schöder, Kaveh Zakeri, Linda Chen, Jung Julie Kang, Sean Matthew McBride, C Jillian Tsai, Daphna Y Gelblum, Jay O Boyle, Jennifer R Cracchiolo, Marc A Co...> ;Oral Oncology. 2023 Jun 1
6 citations
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Anna Lee, Robbie Woods, Amgad Mahfouz, Sarin Kitpanit, Olivia Cartano, Nader Mohamed, Irini Youssef, Kathryn Marqueen, Kevin Sine, Dennis Mah, Brian Neal, Kaveh Zakeri...> ;JAMA Network Open. 2023 Jan 3
8 citations
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulate...
Irini Youssef, Jennifer Yoon, Nader Mohamed, Kaveh Zakeri, Robert H Press, Linda Chen, Daphna Y Gelblum, Sean M McBride, Chiaojung Jillian Tsai, Nadeem Riaz, Yao Yu, M...> ;JAMA Network Open. 2022 Nov 1
27 citations
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulat...
Xingzhe Li, Sarin Kitpanit, Anna Lee, Dennis Mah, Kevin Sine, Eric J. Sherman, Lara Dunn, Loren S. Michel, James Vincent Fetten, Kaveh Zakeri, Yao Yu, Linda Chen, Jung...> ;JAMA Network Open. 2021 Jun 1
1 citations
Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.
Jung Julie Kang, Vatche Tchekmedyian, Nader Mohammed, Alisa Rybkin, S. Kitpanit, Ming Fan, Huili Wang, Stephanie Lobaugh, Zhigang Zhang, Anna Lee, Linda Chen, Yao Yu, ...> ;International Journal of Cancer. 2021 Feb 27
197 citations
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
Sean McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar, Juliana Eng, Wanqing Iris Zhi, Daniel C. McFarland, Loren S. Michel, Robert J. Young, R...> ;Journal of Clinical Oncology. 2021 Jan 1
78 citations
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Uppaluri, R., Campbell, K., Egloff, A., Zolkind, P., Skidmore, Z., Nussenbaum, B., Paniello, R., Rich, J., Jackson, R., Pipkorn, P., Michel, L., Ley, J., Oppelt, P., D...> ;Clinical Cancer Research. 2020 Oct 1
23 citations
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.
S. Kitpanit, Anna Lee, Kenneth L. Pitter, Dan Fan, James C.H. Chow, Brian Neal, Zhiqiang Han, Pamela Fox, Kevin Sine, Dennis Mah, Lara Dunn, Eric J. Sherman, Loren S. ...> ;International Journal of Particle Therapy. 2020 May 28
25 citations
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients wit...
Ming Fan, Jung Julie Kang, Anna Lee, Dan Fan, Huili Wang, S. Kitpanit, Pamela Fox, Kevin Sine, Dennis Mah, Sean McBride, Chiaojung Jillian Tsai, Nadeem Riaz, Lara Dunn...> ;Cancer. 2020 May 1
11 citations
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers
Dan Fan, Jung Julie Kang, Ming Fan, Huili Wang, Anna Lee, Yao Yu, Linda Chen, C. Jillian Tsai, Sean McBride, Nadeem Riaz, Daphna Y. Gelblum, Brian Neal, James Vincent ...> ;Oral Oncology. 2020 May 1
37 citations
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
Lara Dunn, Nadeem Riaz, Matthew G. Fury, Sean McBride, Loren S. Michel, Nancy Y. Lee, Eric J. Sherman, Shrujal S. Baxi, Sofia Haque, Nora Katabi, Richard J. Wong, Han ...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Mar 1
28 citations
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma
Anthony M. Robinson, Richa Rathore, Nathan J. Redlich, Douglas Adkins, Todd VanArsdale, Brian A. Van Tine, Loren S. Michel> ;Cell Death & Disease. 2019 Nov 14
10 citations
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
Loren S Michel, Samantha Dyroff, Frank J Brooks, Katherine J Spayd, Sora Lim, Jacquelyn T Engle, Sharon Phillips, Benjamin Tan, Andrea Wang-Gillam, Christopher Bognar,...> ;Radiology. 2019 Apr 1
7 citations
Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14).
Anna Lee, Julie Kang, Yao Yu, Sean McBride, Nadeem Riaz, Marc Cohen, Eric J. Sherman, Loren S. Michel, Nancy Y. Lee, C. Jillian Tsai> ;International Journal of Particle Therapy. 2019 Mar 1
21 citations
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
Nathan J. Redlich, Anthony M. Robinson, Andrew P. Stein, Deric L. Wheeler, Douglas Adkins, Ravindra Uppaluri, Randall J. Kimple, Brian A. Van Tine, Loren S. Michel> ;Cell Death & Disease. 2018 Jan 5
98 citations
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
Jeff Kremer, Bethany C. Prudner, S.S. Lange, Gregory R. Bean, Matthew Schultze, Caitlyn B. Brashears, Megan D. Radyk, Nathan J. Redlich, Shin-Cheng Tzeng, Kenjiro Kami...> ;Cell Reports. 2017 Jan 24
28 citations
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
Loren S Michel, Samantha Dyroff, Frank J Brooks, Katherine J Spayd, Sora Lim, Jacquelyn T Engle, Sharon Phillips, Benjamin Tan, Andrea Wang-Gillam, Christopher Bognar,...> ;Radiology. 2017 Feb 1
29 citations
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.
Ravindra Uppaluri, Ashley E. Winkler, Tianxiang Lin, Jonathan H. Law, Bruce H. Haughey, Brian Nussenbaum, Randal C. Paniello, Jason T. Rich, Jason Diaz, L. Michel, Tan...> ;Clinical Cancer Research. 2017 May 1
65 citations
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.
Gregory R. Bean, Jeff Kremer, Bethany C. Prudner, Aaron D. Schenone, Juo-Chin Yao, Matthew Schultze, David Y. Chen, Munir R. Tanas, Douglas Adkins, John S. Bomalaski, ...> ;Cell Death & Disease. 2016 Oct 13
14 citations
nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma☆
Douglas Adkins, Jessica Ley, Loren S. Michel, Tanya M. Wildes, Wade L. Thorstad, Mackenzie Daly, Jason T. Rich, Randal C. Paniello, Ravindra Uppaluri, Ryan S. Jackson,...> ;Oral Oncology. 2016 Oct 1
Join now to see all

Grant Support

The Role Of Trop2 In Prostate Stem Cell Biology And TumorigenesisNational Cancer Institute2012
Role Of Notch-Egfr Pathway Cooperativity In Basal-Like Breast CancerNational Cancer Institute2011
Analysis Of Loss Of Function Of MAD2 In MammalsNational Center For Research Resources2006
Analysis Of Loss Of Function Of MAD2 In MammalsNational Cancer Institute2005–2006
Analysis Of Loss Of Function Of MAD2 In MammalsNational Cancer Institute2001–2004

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Spanish

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York
Overlook Medical CenterSummit, New Jersey

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
Anthem HealthKeepers HMO/POS
Anthem KeyCare PPO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Texas BlueChoice
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment